CASE REPORT
Echocardiographic features in infants with dilated cardiomyopathy treated with reversible pulmonary banding: a preliminary single-centre experience
 
More details
Hide details
1
Pediatric Cardiology Department, Children’s Memorial Health Institute, Warsaw, Poland
 
2
Pediatric Cardiosurgery Department, Children’s Memorial Health Institute, Warsaw, Poland
 
3
Cardiovascular Interventions Laboratory, Children’s Memorial Health Institute, Warsaw, Poland 
 
 
Submission date: 2022-10-13
 
 
Final revision date: 2022-11-03
 
 
Acceptance date: 2022-11-14
 
 
Publication date: 2023-06-15
 
 
Corresponding author
Monika Kowalczyk-Domagała
Dr. Monika Kowalczyk-Domagała, The Children’s Memorial Health Institute, Warsaw, Poland
 
 
Pediatr Pol 2023;98(2):161-165
 
KEYWORDS
TOPICS
ABSTRACT
Reversible pulmonary artery banding (rPAB) was proposed as an innovative therapy for young children with end-stage heart failure due to dilated cardiomyopathy (DCM). We report our early experience with rPAB in 2 infants with DCM and preserved right ventricle (RV) function to evaluate the effectiveness of this treatment. Pre- and postoperative echocardiography included standard evaluation of right (RV) and left (LV) ventricle global systolic function. Moreover, we applied the LV global longitudinal strain for better analysis of LV systolic function.
During 15 months of follow-up, clinical and echocardiographic improvement was observed. Our early experience indicates that rPAB may be an effective alternative to heart transplantation or recovery in selected children with DCM.
REFERENCES (9)
1.
Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006; 296: 1867-1876.
 
2.
Lipshultz SE, Law YM, Asante-Korang A, et al. Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association. Circulation 2019; 140: e9-e68.
 
3.
Den Boer SL, du Marchie Sarvaas GJ, Klitsie LM, et al. Longitudinal strain as risk factor for outcome in pediatric dilated cardiomyopathy. JACC Cardiovasc Imaging 2016; 9: 1121-1122.
 
4.
Schranz D, Rupp S, Müller M, et al. Pulmonary artery banding in infants and young children with left ventricular dilated cardiomyopathy: a novel therapeutic strategy before heart transplantation. J Heart Lung Transplant 2013; 32: 475-481.
 
5.
Alvarez JA, Orav EJ, Wilkinson JD, et al. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation 2011; 124: 814-823.
 
6.
Schranz D, Voelkel NF. “Nihilism” of chronic heart failure therapy in children and why effective therapy is withheld. Eur J Pediatr 2016; 175: 445-455.
 
7.
Bauer A, Khalil M, Schmidt D, et al. Transcatheter left atrial decompression in patients with dilated cardiomyopathy: bridging to cardiac transplantation or recovery. Cardiol Young 2019; 29: 355-362.
 
8.
Schranz D, Akintuerk H, Bailey L. Pulmonary artery banding for functional regeneration of end-stage dilated cardiomyopathy in young children: World Network Report. Circulation 2018; 137: 1410-1412.
 
9.
Di Candia A, Castaldi B, Bordin G, et al. Pulmonary artery banding for ventricular rehabilitation in infants with dilated cardiomyopathy: early results in a single-center experience. Front Ped 2020; 8: 347.
 
Journals System - logo
Scroll to top